Context Therapeutics Inc. (CNTX) — Dilution Risk Analysis
Current Snapshot
Context Therapeutics Inc. (CNTX) has a DilutionWatch score of 40/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 40/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: SC 13G/A 3, SC 13G 1, XBRL 1, 4 5.
| Form | Filed | Accession |
|---|---|---|
| SC 13G/A | 2026-08-14 | 0001687078-26-000020 |
| SC 13G/A | 2026-08-12 | 0001140361-26-032506 |
| SC 13G/A | 2026-07-31 | 0001214659-26-009404 |
| SC 13G | 2026-07-27 | 0002012383-26-002242 |
| xbrl | 2026-06-30 | xbrl-4868-xbrl_warrant |
| 4 | 2026-06-26 | 0001628280-26-045762 |
| 4 | 2026-06-26 | 0001628280-26-045789 |
| 4 | 2026-06-26 | 0001628280-26-045775 |
| 4 | 2026-06-26 | 0001628280-26-045778 |
| 4 | 2026-06-26 | 0001628280-26-045780 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 19 months | Source |
| Three-year share count growth | 475.47% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 40/10) Source
- Cash Runway
- 19 months Source
- Share Count Growth (3-Year)
- 475.47% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.